D. Venkat Ratnam, G. Chandraiah, A. K. Meena, P. Rama Rao, M. N. V. Ravi Kumar. The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats. Journal of Nanoscience and Nanotechnology (In Press)

J. Shaikh, D. D. Ankola, V. Beniwal, D. Singh, and M. N. V. Ravi Kumar. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9 fold when compared to curcumin administered with piperine as absorption enhancer. European Journal of Pharmaceutical Sciences 37 (2009) 223-230

J. L. Italia, M. M. Yahya, D. Singh, and M. N. V. Ravi Kumar, Biodegradable nanoparticles improve oral bioavailability of Amphotericin B and shows reduced nephrotoxicity against intravenous Fungizone®, Pharmaceutical Research 26 (2009) 1324-1331

G. Mittal and M. N. V. Ravi Kumar, Impact of polymeric nanoparticles on oral pharmacokinetics: A dose-dependent case study with estradiol. Journal of Pharmaceutical Sciences (In Press)

J. L. Italia, D. Singh, M. N. V. Ravi Kumar, High-performance liquid chromatographic analysis of amphotericin B in rat plasma using alpha-naphthol as an internal standard, Analytica Chimica Acta 634 (2009) 110-114

D. R. Kalaria, G. Sharma, V. Beniwal and M. N. V. Ravi Kumar, Design of biodegradable nanoparticles for oral delivery of Doxorubicin: In vivo pharmacokinetics and toxicity studies in rats, Pharmaceutical Research 26 (2009) 492-501

G. Mittal, G. Chandraiah, P. Ramarao and M. N. V. Ravi Kumar, Pharmacodynamic evaluation of oral estradiol nanoparticles in estrogen deficient (ovariectomized) high-fat diet induced hyperlipidemic rat model, Pharmaceutical Research, 26 (2009) 218-223

A. K. Meena, D. Venkat Ratnam , G. Chandraiah, D.D. Ankola, P. Rama Rao and M.N.V. Ravi Kumar, Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia, Lipids 43 (2008) 231-241

D. Sahana, G. Mittal, V. Bhardwaj and M. N. V. Ravi Kumar, PLGA Nanoparticles for Oral Administration of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug, Journal of Pharmaceutical Sciences 97 (2008) 1530-1542

J.L. Italia, D.K. Bhatt, V. Bhardwaj, K. Tikoo and M.N.V. Ravi Kumar. PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral Journal of Controlled Release 119 (2007) 197-206

K. Sonaje, J. Italia, G. Sharma, V. Bhardwaj, K. Tikoo and M. N. V. Ravi Kumar, Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats, Pharmaceutical Research 24 (2007) 899-908

G. Sharma, J. L. Italia, K. Sonaje, K. Tikoo and M. N. V. Ravi Kumar, Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: Evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats Journal of Controlled Release 118 (2007) 27-37

N. Kashyap, B. Viswanad, G. Sharma, V. Bhardwaj, P. Rama Rao and M. N. V. Ravi Kumar, Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin, Biomaterials 28 (2007) 2051-2060